Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan-Feb:44:16-21.
doi: 10.1016/j.genhosppsych.2016.10.002. Epub 2016 Oct 22.

Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up

Affiliations

Post-surgical depressive symptoms and long-term survival in non-metastatic breast cancer patients at 11-year follow-up

Michael H Antoni et al. Gen Hosp Psychiatry. 2017 Jan-Feb.

Abstract

Background: Mild to moderate depressive symptoms are common during treatment for non-metastatic breast cancer. The goal of this secondary analysis was to determine if depressive symptoms predict clinical outcomes at long-term follow-up.

Methods: From 1998 to 2005, we interviewed 231 women with the Hamilton Rating Scale for Depression who were participating in a psychosocial study 2-10weeks post-surgery for non-metastatic breast cancer (Stage 0-IIIb). We conducted Kaplan Meier (K-M) curves and Cox proportional hazards (PH) models to examine associations between depressive symptoms, overall survival, and disease-free survival at 8-15-year follow-up.

Results: A total of 95 women (41.1%) scored in the mild-moderately depressed range. Non-depressed women had longer overall survival (M=13.56years; SE=0.26) than those in the mild/moderate depressed group (M=11.45years; SE=0.40), Log-rank χ2(1)=4.41, p=0.036. Cox PH models, adjusting for covariates, showed comparable results: mild/moderate depressive symptoms hazard ratio=2.56, [95% CI, 1.11 to 5.91], p=0.027. Similar results were observed in a subsample with invasive disease (n=191). Depression category did not predict disease-free survival in the overall or invasive sample.

Conclusions: Screening and referrals for treatment of depressive symptoms, even at subclinical levels, is important early in treatment. A randomized trial is warranted to determine effects of depressive symptoms on clinical outcomes.

Keywords: Breast neoplasms; Depressive symptoms; Follow-up study; Recurrence; Survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Full sample: KM survival function for women classified as High (HDRS >7) vs. Low (HDRS ≤7) at study entry Note: HDRS = Hamilton Depression Rating Scale
Figure 2
Figure 2
Full Sample: Cox PH model for overall survival (using 0.6 – 1.0 scaling) for women classified as no/low (0-7), mild (8-16), or moderate (17-23) depressive symptoms at study entry Note: HDRS = Hamilton Depression Rating Scale

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians 2016. 66:7–30. doi: 10.3322/caac.21332. - PubMed
    1. Antoni MH, Wimberly SR, Lechner SC, et al. Reduction of cancer-specific thought intrusions and anxiety symptoms with a stress management intervention among women undergoing treatment for breast cancer. American Journal of Psychiatry. 2006;163:1791–1797. doi: 10.1176/ajp.2006.163.10.1791. - PMC - PubMed
    1. Lutgendorf SK, Sood AK, Antoni MH. Host factors and cancer progression: biobehavioral signaling pathways and interventions. Journal of Clinical Oncology. 2010;28:4094–4099. doi: 10.1200/JCO.2009.26.9357. - PMC - PubMed
    1. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nature Clinical Practice: Oncology. 2008;5:466–475. doi: 10.1038/ncponc1134. - PubMed
    1. Cohen L, Cole SW, Sood AK, et al. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PloS One. 2012;7:e42324. doi: 10.1371/journal.pone.0042324. - PMC - PubMed